Phase 1-2 Study of Injection of Melphalan Into the Ophthalmic Artery in Children With Retinoblastoma
Phase 1/Phase 2
6 Months
10 Years
6 Months
10 Years
Open (Enrolling)
Both
Retinoblastoma
Both
Retinoblastoma
Trial Information
Phase 1-2 Study of Injection of Melphalan Into the Ophthalmic Artery in Children With Retinoblastoma
Inclusion Criteria:
- Children with retinoblastoma in a single remaining eye with useful vision
Exclusion Criteria:
- None
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Salvage of eye and vision
Outcome Time Frame:
Three years from intervention
Safety Issue:
No
Authority:
Israel: Ministry of Health
Study ID:
0058-09-HMO
NCT ID:
NCT00906113
Start Date:
June 2011
Completion Date:
Related Keywords:
- Retinoblastoma
- Retinoblastoma
- Retinoblastoma
Name | Location |
|---|
